N-terminal pro-B-type natriuretic peptide levels vary by ethnicity and are associated with insulin sensitivity after gestational diabetes mellitus

被引:0
|
作者
Sharma, Archana [1 ,7 ]
Birkeland, Kare I. [2 ,3 ]
Nermoen, Ingrid [1 ,2 ]
Sommer, Christine [3 ]
Qvigstad, Elisabeth [2 ,3 ]
Lee-odegard, Sindre [2 ,3 ]
Sveen, Kari A. [2 ,3 ]
Sattar, Naveed [4 ]
Sollid, Stina T. [5 ]
Omland, Torbjorn [2 ,6 ]
Myhre, Peder L. [2 ,6 ]
机构
[1] Akershus Univ Hosp, Dept Endocrinol, Lorenskog, Norway
[2] Univ Oslo, Inst Clin Med, Oslo, Norway
[3] Oslo Univ Hosp, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway
[4] Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, 126 Univ Pl, Glasgow G12 8TA, Scotland
[5] Vestre Viken Trust, Dept Med, Drammen Hosp, Drammen, Norway
[6] Akershus Univ Hosp, Dept Cardiol, Lorenskog, Norway
[7] Campus Akershus Univ Hosp, Dept Endocrinol, N-1478 Lorenskog, Norway
关键词
NT-proBNP; Ethnicity; Gestational diabetes mellitus; Heart disease; Insulin sensitivity; Normoglycemia; Prediabetes; Prevention; C-REACTIVE PROTEIN; HEART-FAILURE; CENTRAL OBESITY; ADIPOSE-TISSUE; SOUTH ASIANS; RISK; RESISTANCE; WOMEN; INDIVIDUALS; CLEARANCE;
D O I
10.1186/s12933-024-02349-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Individuals of South Asian origin have a greater risk of cardiovascular disease after gestational diabetes mellitus (GDM) than European individuals. B-type natriuretic peptide (BNP) and the amino-terminal fragment of its prohormone (NT-proBNP) are commonly used for heart failure screening and diagnosis, but biologically BNP exerts several beneficial cardiovascular effects primarily by counteracting the renin-angiotensin-aldosterone-system. We asked whether ethnic differences in circulating NT-proBNP levels could be explained by the differences in cardiometabolic and inflammatory risk markers? Methods We examined 162 South Asian and 107 Nordic women in Norway 1-3 years after GDM with a clinical examination, fasting blood samples and an oral glucose tolerance test. We measured the levels of NT-proBNP, high-sensitivity cardiac troponin T, high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), leptin, adiponectin and markers of insulin sensitivity, such as the Matsuda insulin sensitivity index (ISI). Finally, we tried to identify which independent covariate best mediated the ethnic differences in NT-proBNP. Results The mean (SD) age was 35.3 (4.5) years, BMI 29.1 (6.0) kg/m(2), waist-height ratio 0.60 (0.08) and 164 women (61%) had prediabetes/diabetes. Notably, South Asian women had lower levels of NT-proBNP than Nordic women in both the normoglycemic and prediabetes/diabetes groups (median (IQR) 26 (15-38) vs. 42 (22-66) ng/L, p < 0.001). Higher NT-proBNP levels were associated with greater insulin sensitivity in both South Asian and Nordic women (p = 0.005 and p < 0.001). South Asian women had higher levels of hsCRP (median (IQR) 2.2 (1.1-4.4) vs. 1.2 (0.3-4.2) mg/L), IL-6 (2.3 (1.5-3.2) vs. 1.5 (1.5-2.5) pg/mL), leptin (1647 (1176-2480) vs. 1223 (876-2313) pmol/L), and lower adiponectin levels (7.2 (5.3-9.3) vs. 10.0 (7.2-13.5) mg/L) and Matsuda ISI (2.4 (1.7-3.7) vs. 4.2 (2.9-6.1), p(all)<0.01) than Nordic women. Even after adjusting for these differences, higher NT-proBNP levels remained associated with insulin sensitivity (22% higher NT-proBNP per SD Matsuda ISI, p = 0.015). Insulin sensitivity and adiponectin mediated 53% and 41% of the ethnic difference in NT-proBNP. Conclusions NT-proBNP levels are lower in South Asian than in Nordic women after GDM. Lower NT-proBNP levels correlate with impaired insulin sensitivity. Lower NT-proBNP levels in South Asian women could, therefore, be attributed to impaired insulin sensitivity rather than total body fat.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Sex-specific associations of obesity and N-terminal pro-B-type natriuretic peptide levels in the general population
    Suthahar, Navin
    Meijers, Wouter C.
    Ho, Jennifer E.
    Gansevoort, Ron T.
    Voors, Adriaan A.
    van der Meer, Peter
    Bakker, Stephan J. L.
    Heymans, Stephane
    van Empel, Vanessa
    Schroen, Blanche
    van der Harst, Pim
    van Veldhuisen, Dirk J.
    de Boer, Rudolf A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (08) : 1205 - 1214
  • [2] Serum levels of N-terminal pro-B-type natriuretic peptide are associated with allograft function in recipients of renal transplants
    Bodlaj, Gerd
    Hubmann, Rainer
    Saleh, Karim
    Biesenbach, Georg
    Pohanka, Erich
    Stojakovic, Tatjana
    Berg, Joerg
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 (19-20) : 631 - 637
  • [3] N-Terminal Pro-B-Type Natriuretic Peptide A Risk Predictor for All
    Douglas, Pamela S.
    Felker, G. Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (17) : 1798 - 1800
  • [4] N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes
    Ezekowitz, Justin A.
    O'Connor, Christopher M.
    Troughton, Richard W.
    Alemayehu, Wendimagegn G.
    Westerhout, Cynthia M.
    Voors, Adriaan A.
    Butler, Javed
    Lam, Carolyn S. P.
    Ponikowski, Piotr
    Emdin, Michele
    Patel, Mahesh J.
    Pieske, Burkert
    Roessig, Lothar
    Hernandez, Adrian F.
    Armstrong, Paul W.
    JACC-HEART FAILURE, 2020, 8 (11) : 931 - 939
  • [5] N-Terminal Pro-B-Type Natriuretic Peptide Is Inversely Associated With Metabolic Syndrome in Hypertensive Patients
    Chang, Huai-Ren
    Hsieh, Jen-Che
    Hsu, Bang-Gee
    Wang, Ling-Yi
    Chen, Michael Yu-Chih
    Wang, Ji-Hung
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2014, 348 (03) : 210 - 214
  • [6] N-terminal pro-B-type natriuretic peptide in early and advanced phases of obesity
    Mangge, Harald
    Almer, Gunter
    Zelzer, Sieglinde
    Vasan, Ramachandran
    Kraigher-Krainer, Elisabeth
    Gasser, Robert
    Schnedl, Wolfgang
    Ille, Rottraut
    Wallner, Sandra
    Moeller, Reinhard
    Horejsi, Renate
    Weghuber, Daniel
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (09) : 1539 - 1545
  • [7] N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study
    Patton, Kristen K.
    Sotoodehnia, Nona
    DeFilippi, Christopher
    Siscovick, David S.
    Gottdiener, John S.
    Kronmal, Richard A.
    HEART RHYTHM, 2011, 8 (02) : 228 - 233
  • [8] N-Terminal Pro-B-Type Natriuretic Peptide and Longitudinal Risk of Hypertension
    Nicoli, Charles D.
    Plante, Timothy B.
    Long, D. Leann
    Judd, Suzanne E.
    McClure, Leslie A.
    Arora, Pankaj
    Cushman, Mary
    AMERICAN JOURNAL OF HYPERTENSION, 2021, 34 (05) : 476 - 483
  • [9] N-terminal Pro-B-Type Natriuretic Peptide and Malnutrition in Patients on Hemodialysis
    Ducros, Jacques
    Larifla, Laurent
    Merault, Henri
    Galantine, Valerie
    Bassien-Capsa, Valerie
    Foucan, Lydia
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2020, 2020
  • [10] N-terminal pro-B-type natriuretic peptide levels and early outcome after cardiac surgery: a prospective cohort study
    Cuthbertson, B. H.
    Croal, B. L.
    Rael, D.
    Gibson, P. H.
    McNeilly, J. D.
    Jeffrey, R. R.
    Smiths, W. Cairns
    Prescott, G. J.
    Buchan, K. G.
    El-Shafei, H.
    Gibson, G. A.
    Hillis, G. S.
    BRITISH JOURNAL OF ANAESTHESIA, 2009, 103 (05) : 647 - 653